infectious-diseases

Documents about infectious-diseases

• The Novel Carbapenem, JDB/PQ-1-219, Has Potent Broad Spectrum Activity against Multi-Drug Resistant Acinetobacter baumannii#287782Figshare
• Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study#299094Springer Nature OA
• Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity#299105Springer Nature OA
• Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis#299106Springer Nature OA
• Integrative transcriptomic analysis uncovers the microRNA-centric regulation of Japanese encephalitis virus infection in porcine trophoblast cells#304122Figshare
• Lipid-based nanocarriers as transformative treatment in tuberculosis: a systematic review of therapeutic efficacy#320102Figshare
• Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults#325160ClinicalTrials.gov
• Autopsy practices for high-consequence infectious diseases: global guidelines, alternatives, and the BSL-4 gap.#327606PubMed
• Pretreatment HIV drug resistance in low- and middle-income countries#341983Apollo
• Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis#347365Figshare
• Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis#347366Figshare
• Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey#355761Springer Nature OA
• Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study#355763Springer Nature OA
• A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160#381829ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants#390973ClinicalTrials.gov
• Modeling Ambient Oxidation of Aerosol Oleic Acid with Bayesian Statistics#405501Figshare
• Noninvasive treatment strategy for abdominal wall desmoid tumors applying high-intensity focused ultrasound#433210Figshare
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals#444763ClinicalTrials.gov
• Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa#454083ClinicalTrials.gov
• Comparison of the Hospital Burden Associated with Respiratory Syncytial Virus and Human Metapneumovirus Across All Age Groups in Scotland: A Retrospective Analysis#456069Springer Nature OA
• Analysis of the Economic and Public Health Impact of New Immunization Strategies in Infants Against Respiratory Syncytial Virus (RSV) in Colombia#456070Springer Nature OA
• Data and scripts from: Pathogen spillover driven by rapid changes in bat ecology. Food shortage regression tree model#493649Cornell eCommons
• A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults#141109ClinicalTrials.gov
• Climate drivers and winter constraints of dengue epidemics: a 10-year epidemiological perspective study in the Lao People’s Democratic Republic#147717Springer Nature OA
• Comparative effectiveness of mRNA-1273 versus protein-based NVX-CoV2705 vaccination on COVID-19-related outcomes among US insured adults during 2024--2025: a retrospective matched cohort study#151592bioRxiv / medRxiv
• Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults#152498ClinicalTrials.gov
• Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048#154702ClinicalTrials.gov
• Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults#195408ClinicalTrials.gov
• <p>Disease burden of asbestos- attributable cancers in China in 2023 by age group and sex.</p>#195592Figshare
• Prevalence and Risk Factors of Respiratory Tract Infections Following Medically-Attended-Diarrhea in Children Aged 6-35 Months: Enterics for Global Health (EFGH)-Shigella Surveillance Study, 2022-2024.#200183bioRxiv / medRxiv
• Cascade Cloke–Wilson Rearrangement of Enyne-Amides and 2‑Bromomalonates to Construct 2,3-Furan-Fused Dihydropyrroles#212935Figshare
• Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy#217095ClinicalTrials.gov
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Additional file 2 of 1H NMR-based metabolomics reveals metabolic changes in porcine ingesta and serum during Ascaris suum infection#221763Figshare
• Additional file 1 of 1H NMR-based metabolomics reveals metabolic changes in porcine ingesta and serum during Ascaris suum infection#221764Figshare
• Neglected rickettsial diseases in Southeast Asia: Twenty-five years of progress in surveillance, diagnostics, and clinical research#228189PLOS
• Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults#234485ClinicalTrials.gov
• Changes in tobacco sales before, during, and after the COVID-19 pandemic in Japan: An interrupted time series analysis#265690PLOS
• Additional file 2 of Chemical profile, anti-biofilm and antioxidant activities of Cymbopogon citratus (DC.) Stapf essential oil#296742Figshare
• Additional file 1 of Chemical profile, anti-biofilm and antioxidant activities of Cymbopogon citratus (DC.) Stapf essential oil#296744Figshare
• HA thermostability mutations S84F, G167N, and D168N potentiate H9N2 virus transmission in a warming environment#307749Figshare
• Antibiofilm effects of poly(2-methoxyethyl acrylate) coating via inhibition of protein adsorption on catheter surfaces#347327Figshare
• Identity-Based Behavioral Economic Incentives Increased PrEP Adherence for Transgender and Nonbinary Adults in a Trans-Led PrEP Navigation Program#368914Springer Nature OA
• Atomic Layer Deposition of High-Density GeSe Films for Stable Vertical Ovonic Threshold Switching and Selector-Only Memory#384367Figshare
• Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease#401988DataCite
• Ultrafast Nano-imaging and Optical Control of Hyperbolic Phonon Polaritons at hBN/WS₂ Heterojunctions#403903Figshare
• Nickel-Catalyzed Electrophilic Cross-Coupling Reaction of a Pyridylsulfonyl Monofluoro Reagent with Aromatic Bromides#403916Figshare
• Low-Load Plyometric Training to Improve Running in Children With Generalised Joint Hypermobility: A Single Subject Research Design#430050Figshare
• Maternal mortality from obstetric hemorrhage in Brazil: a 10-year analysis (2015 to 2024)#433189Figshare
• Diagnosis of genital herpes simplex virus infection in the clinical laboratory.#445556HAL Science